Tradestie Institutional Equity Comparison Engine

CRMD vs CTMX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRMD Overall Edge

CRMD Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin, Options & Structure while CTMX counters with relative strength in Momentum & Technical. Fundamentally, CRMD trades at 49.0x Forward P/E with 41.0% operating margin (-47.7% YoY revenue) versus CTMX at 14.2x Forward P/E and -676.4% operating margin (-71.7% YoY). In options structure, CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against CTMX sits in BREAKDOWN (60th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
CRMD 49.0x vs CTMX 14.2x Fwd P/E
Growth & Margin Winner CRMD
Op Margin 41.0% vs -676.4% ยท YoY -47.7% vs -71.7%
Momentum & Technical Winner CTMX
1Y -56.2% vs -49.4% ยท 52W Pos 3% vs 1%
Options & Structure Winner CRMD
BREAKDOWN (25th %ile IV) vs BREAKDOWN (60th %ile IV)
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0
CTMX NASDAQ
CytomX Therapeutics, Inc.
Pharmaceutical Preparations
$1.96
-4.17% 1D
Market Cap $436.0M
1M Return -14.25%
1Y Return -49.35%
Forward P/E 14.2x
Unified AI Score
53.1 / 100 HOLD
Tech 66.0 Fund 64.0 Flow 69.0 Mom 49.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRMD -56.16% CTMX -49.35% Spread: +6.81 pp (CTMX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRMD Revenue CTMX Revenue CRMD Op. Margin CTMX Op. Margin Margin Edge
FY2018 $0M $60M -6250.4% -130.9% CTMX
FY2019 $0M $30M -7416.3% -525.9% CTMX
FY2020 $0M $70M -11378.4% -117.7% CTMX
FY2021 $0M $40M -15417.5% -311.0% CTMX
FY2022 $0M $50M -46819.9% -190.6% CTMX
FY2023 N/A $100M N/A -6.4% CTMX
FY2024 $40M $140M -51.4% 18.1% CTMX
FY2025 $310M $80M 48.2% -29.3% CRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRMD (6) vs CTMX (3)
Institutional Metric CRMD CTMX Criterion Row Winner
Market Capitalization Scale $384.7M $436.0M Larger Scale CTMX
Trailing P/E Ratio Valuation 2.4x 14.2x Lower Multiple CRMD
Forward P/E Ratio Valuation 49.0x 14.2x Lower Multiple CTMX
Revenue Growth (YoY) Growth -47.7% -71.7% Higher Growth CRMD
Operating Margin (TTM) Profitability 41.0% -676.4% Higher Margin CRMD
Net Profit Margin Profitability 15.5% 0.0% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency 15.3% -43.5% Higher ROE CRMD
52-Week Range Position Momentum 3% ($5โ€“$13) 1% ($2โ€“$8) Stronger Trend CRMD
Beta / 30D Volatility Risk Regime 1.20ฮฒ ยท 107% Vol 1.48ฮฒ ยท 78% Vol Lower Realized Risk CTMX
Unified Institutional Score Composite Signal 53.2 / 100 (HOLD) 53.1 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRMD vs CTMX Buy Guide
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CTMX BREAKDOWN
170d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 60th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CTMX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRMD nor CTMX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.